Therapeutic Area | MeSH |
---|---|
skin and connective tissue diseases | D017437 |
immune system diseases | D007154 |
Brand Name | Status | Last Update |
---|---|---|
cellcept | New Drug Application | 2025-05-19 |
mycophenolate mofetil | ANDA | 2025-07-01 |
mycophenolic acid | ANDA | 2025-06-06 |
myfortic | New Drug Application | 2025-05-01 |
myhibbin | New Drug Application | 2024-05-07 |
Code | Description |
---|---|
J7518 | Mycophenolic acid, oral, 180 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Systemic lupus erythematosus | D008180 | EFO_0002690 | M32 | — | — | — | 1 | 1 | 2 |
Systemic scleroderma | D012595 | EFO_0000717 | M34 | — | 1 | — | 1 | — | 2 |
Myositis | D009220 | EFO_0000783 | G72.49 | — | — | — | 1 | — | 1 |
Juvenile arthritis | D001171 | EFO_1002007 | M08 | — | — | — | 1 | — | 1 |
Behcet syndrome | D001528 | EFO_0003780 | M35.2 | — | — | — | 1 | — | 1 |
Dermatomyositis | D003882 | EFO_0000398 | M33 | — | — | — | 1 | — | 1 |
Ankylosing spondylitis | D013167 | EFO_0003898 | M45 | — | — | — | 1 | — | 1 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | — | — | 1 | — | 1 |
Arthritis | D001168 | EFO_0005856 | M05-M14 | — | — | — | 1 | — | 1 |
Vasculitis | D014657 | EFO_0006803 | M31 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lupus nephritis | D008181 | EFO_0005761 | — | — | — | 1 | — | — | 1 |
Nephritis | D009393 | — | N05 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Kidney transplantation | D016030 | — | — | — | 2 | — | — | — | 2 |
Delayed graft function | D051799 | — | — | — | 1 | — | — | — | 1 |
Diffuse scleroderma | D045743 | EFO_0000404 | — | — | 1 | — | — | — | 1 |
Sclerosis | D012598 | — | — | — | 1 | — | — | — | 1 |
Drug common name | Mycophenolic acid |
INN | mycophenolic acid |
Description | Mycophenolic acid is a member of the class of 2-benzofurans that is 2-benzofuran-1(3H)-one which is substituted at positions 4, 5, 6, and 7 by methyl, methoxy, (2E)-5-carboxy-3-methylpent-2-en-1-yl, and hydroxy groups, respectively. It is an antibiotic produced by Penicillium brevi-compactum, P. stoloniferum, P. echinulatum and related species. An immunosuppressant, it is widely used (partiularly as its sodium salt and as the 2-(morpholin-4-yl)ethyl ester prodrug, mycophenolate mofetil) to prevent tissue rejection following organ transplants and for the treatment of certain autoimmune diseases. It has a role as an antineoplastic agent, an antimicrobial agent, an EC 1.1.1.205 (IMP dehydrogenase) inhibitor, an immunosuppressive agent, a mycotoxin, a Penicillium metabolite, an environmental contaminant, a xenobiotic and an anticoronaviral agent. It is a gamma-lactone, a member of phenols, a monocarboxylic acid and a member of 2-benzofurans. It is functionally related to a hex-4-enoic acid. It is a conjugate acid of a mycophenolate. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2 |
PDB | — |
CAS-ID | 24280-93-1 |
RxCUI | — |
ChEMBL ID | CHEMBL866 |
ChEBI ID | 168396 |
PubChem CID | 446541 |
DrugBank | DB01024 |
UNII ID | HU9DX48N0T (ChemIDplus, GSRS) |